It was 3 a.m. in Los Angeles, California. Richard McDonald was drifting between sleep and wakefulness when he heard these words on his radio: “If you once had vision but are now blind and would like to participate in the first clinical trial for a brain implant…”
At first, he thought he was dreaming. Then, he decided he had to act.
Now, Richard is one of just six people living with artificial vision as part of a revolutionary FDA clinical trial for an innovative medical technology to treat blindness.